drugset

drugset / Trial / NCT00893724

Supplemental Adjuvants for Intracellular Nutrition and Treatment

NCT00893724 ↗

Unknown 60 enrolled Mid-Atlantic Retina Consultations, Inc. West Virginia University · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

Nutritional supplements have an augmentative effect on the outcomes of standard treatment of diabetic macular edema (DME) and Neovascular Age-Related Macular Degeneration (NAMD).

Timeline

Start: 2009-06
Primary completion: 2011-08
Completion: 2011-09

Publications

Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev. 2023 Sep 13;9(9):CD000254. doi: 10.1002/14651858.CD000254.pub5.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Coenzyme Q10	Other / unclassified	50 mg	—
Comparator	Inosine	Unknown	500 mg	—
Comparator	Minocycline	Small molecule	50 mg	—
Comparator	N-acetylcysteine	Small molecule	600 mg	—
Comparator	Nicotinamide	Other / unclassified	750 mg	—
Comparator	Tocotrienol	Small molecule	10 mg	—
Comparator	Vitamin C	Other / unclassified	1000 mg	—
Comparator	Vitamin E	Other / unclassified	200 iu	—

Indications